11/15
03:26 pm
kala
KALA BIO, Inc. (NASDAQ: KALA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Low
Report
KALA BIO, Inc. (NASDAQ: KALA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
11/12
08:00 am
kala
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update